Device Trial Radar · NCT01535612
Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Jul 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Mar 2012
Primary completion
Aug 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- CeQur CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- International Diabetes Center at Park Nicollet
- First posted
- Feb 20, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the ability of a patient, who has type 2 diabetes (T2DM) who is currently treated with basal/bolus insulin therapy, to use PaQ™ (a simple patch on insulin delivery device) to control his/her blood glucose.
Conditions
- Type 2 Diabetes Mellitus
Interventions
PaQ™ insulin infusion deviceDevice
Basal/bolus insulin therapy administered by CSII for 4 weeks. First two weeks is transition period to identify correct basal rate for the patient, second 2 weeks is treatment period to evaluate efficacy of CSII device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patients ability to successfully assemble, fill, prime, apply and use the PaQ™ deviceTime frame: End of two week transition period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical University of Graz
Graz, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.